https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694112/
But note, now claiming post hoc analysis
Also not clear how long the patients had had COPD. Fibrotic lung damage that has consolidated and scarred has not been much amenable to treatment AFAIK. Much better to prevent or treat early...
On a side note https://www.sciencedaily.com/releases/2018/07/180703131423.htm
Metformin reverses established lung fibrosis
Diabetes drug a potential therapy for idiopathic pulmonary fibrosis, suggests research with human lung fibroblasts, mouse model of lung fibrosis
Date: July 3, 2018- Source: University of Alabama at Birmingham
- Summary:
- Researchers have shown -- for the first time -- that established lung fibrosis can be reversed using a drug treatment that targets cell metabolism. The finding is important because, despite significant advances to reveal the pathological mechanisms of persistent fibrosis, effective treatment interventions are lacking.
...
Using a mouse model for lung fibrosis elicited by the anti-cancer drug bleomycin, the research team found metformin treatment, starting three weeks after lung injury and continuing for five weeks, accelerated the resolution of well-established fibrosis. Such resolution was not apparent in AMPK-knockout mice, showing that the effect of metformin was AMPK-dependent.
...
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-1998
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B |
Open | High | Low | Value | Volume |
$1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5127 | $1.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.57 | 39613 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5127 | 1.565 |
3 | 15000 | 1.560 |
2 | 8950 | 1.545 |
3 | 52000 | 1.540 |
1 | 100000 | 1.525 |
Price($) | Vol. | No. |
---|---|---|
1.570 | 14365 | 2 |
1.580 | 57756 | 6 |
1.585 | 5500 | 1 |
1.590 | 3123 | 1 |
1.600 | 5000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online